Your browser doesn't support javascript.
loading
Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology.
Barth, Kaia; Gill, Harsimrat; Singh, Namrata.
Affiliation
  • Barth K; Fellow, Division of Rheumatology.
  • Gill H; Medical Student, Department of Medicine.
  • Singh N; Assistant Professor, Division of Rheumatology.
Curr Opin Rheumatol ; 36(2): 113-119, 2024 03 01.
Article in En | MEDLINE | ID: mdl-38126228
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatology / Biological Products / Antirheumatic Agents / Janus Kinase Inhibitors / Synthetic Drugs Limits: Humans Language: En Journal: Curr Opin Rheumatol Journal subject: REUMATOLOGIA Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatology / Biological Products / Antirheumatic Agents / Janus Kinase Inhibitors / Synthetic Drugs Limits: Humans Language: En Journal: Curr Opin Rheumatol Journal subject: REUMATOLOGIA Year: 2024 Document type: Article Country of publication: